Remove clinical sleep
article thumbnail

Sleep Or Depression? Trazodone’s Dose Dependent Clinical Response

Med Ed 101

What’s interesting about trazodone is the drug’s wide dosing range – with lower doses (25-150 mg) effectively managing insomnia […] The post Sleep Or Depression? Trazodone’s Dose Dependent Clinical Response appeared first on Med Ed 101.

article thumbnail

No Sleep ‘Til District Court: Jazz Sues FDA Over Sodium Oxybate Clinical Superiority Determination

The FDA Law Blog

This time, rather than use codes and patent certifications, the fight is over orphan drug exclusivity (“ODE”), with Jazz challenging FDA’s clinical superiority decision concerning sodium oxybate in the treatment of narcolepsy. 360cc(c), the statute does not permit FDA to promulgate regulations to use clinical superiority to break ODE.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cleveland Clinic Study: Long COVID Shows Link to Sleep Disturbances

Pharmacy Times

41% of patients report moderate-to-severe issues, with Black individuals 3 times more likely to develop these difficulties.

123
123
article thumbnail

Does gabapentin help you sleep?

The Checkup by Singlecare

Gabapentin for sleep | When to take gabapentin for sleep | Dosage | Risks | Alternatives Getting enough sleep is one of the most important ways to support your health. don’t get enough sleep. Not getting enough sleep can lead to chronic diseases, such as diabetes , heart disease , and stroke.

Dosage 97
article thumbnail

Can you take ibuprofen and melatonin together?

The Checkup by Singlecare

Melatonin is a generic sleep aid supplement that promotes improved sleep patterns by adjusting the body’s circadian rhythm, or sleep-wake cycle. They are sometimes used together, particularly for people who struggle to sleep due to pain. Ibuprofen helps with the pain, and melatonin works to improve sleep quality.

article thumbnail

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

STAT

The biotech reported Monday that its drug, the antisense oligonucleotide treatment GTX-102, was generally safe and led to rapid and clinically meaningful improvements in cognition, communication, and sleep. The next step is a meeting with the Food and Drug Administration to discuss the findings and plans for a Phase 3 pivotal study.

article thumbnail

STAT+: Pharmalittle: We’re reading about Lilly’s Zepbound for sleep apnea, the FDA budget, and more

STAT

Have a wonderful day, and please do stay in touch… Eli Lilly reported positive results for its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market , STAT tells us. adults, though many cases are undiagnosed, according to the National Council on Aging.